Navigation Links
Neurology in Medical Technology

Study Results of GAMMAGARD S/D and GAMMAGARD LIQUID in Patients with Mild-to-Moderate Alzheimer's Disease Announced

... announced at the American Academy of neurology annual meeting CHICAGO, April 17 ... disease today at the American Academy of neurology (AAN) annual meeting in Chicago. The study met ... Center, and associate professor of clinical neurology at Weill Cornell Medical College in New York ....

Study Results Show That Minimally Invasive Therapy is Successful for Over Two-Thirds of Stroke Patients Treated Outside the Standard Eight-Hour Window

... According to lead author Raul Nogueira, M.D., Assistant in neurology and Radiology at Massachusetts General Hospital -- Harvard Medical School, ... practitioners with backgrounds in neuroradiology, neurosurgery and neurology that come together in the shared discipline of neurointerventional ....

Data Suggest Sodium Oxybate Significantly Improves Pain and the Core Symptoms of Fibromyalgia

... Director of the Houston Sleep Center and Assistant Clinical Professor of neurology at the University of Texas-Houston School of Medicine. "Millions of ... commercializes innovative treatments for important, underserved markets in neurology and psychiatry. For further information see ...

NeurogesX Announces Publication of Phase 3 Data for QUTENZA(TM) (NGX-4010) in Postherpetic Neuralgia (PHN) by The Lancet Neurology

... neuralgia (PHN) in the December 2008 print edition of The Lancet neurology . The article is also available through Lancet Online at ... management of peripheral neuropathic pain. The paper in The Lancet neurology titled, "NGX-4010, a high-concentration capsaicin patch, for the ...

Roskamp Institute Identifies New Class of Drugs to Treat Alzheimer's Disease

... researcher with Dr. Michael Wolfe at Harvard Medical School , Center for neurology from 2001-2004 and a sabbatical postdoctoral fellow at Harvard Medical School , Laboratory of Drug Discovery in neurology with Dr. Michael Wolfe and Dr. Ross Stein from 2002-2003. Dr. Bakshi has ...

TorreyPines Therapeutics to Host Webinar at 11 a.m. EDT Today on the Opportunity for Treating Chronic Pain, Migraine and Muscle Spasticity Through Inhibition of Neurotransmitter Glutamate

... headache therapies. -- Alan J. Tuchman, M.D., Clinical Professor of neurology and Pharmacology at New York Medical College, Principal of ... spasticity. He has served as Vice Chairman of the Department of neurology at New York Medical College as well as Vice Dean of Clinical Affairs, ...

Medivation's Dimebon(TM) Significantly Improved Thinking and Memory in Alzheimer's Disease Patients Over One Year

... Data from Pivotal Trial Presented at American Academy of neurology 60th Annual Meeting - SAN FRANCISCO and CHICAGO, April 17 ... an oral presentation at the 60th Annual Meeting of the American Academy of neurology (AAN) by Steven H. Ferris, Ph.D., the Gerald J. and Dorothy R. Friedman ...

Data Presented at AAN Show That Lacosamide Significantly Reduced Pain and was Generally Well Tolerated in Patients With Diabetic Neuropathic Pain

... at the 60th Annual Meeting of the American Academy of neurology (AAN) in Chicago SMYRNA, Ga., April 16 /PRNewswire/ -- UCB presented ... which were presented at the 60th Annual Meeting of the American Academy of neurology (AAN) in Chicago, showed that lacosamide significantly reduced pain in ...

FTY720, a novel oral therapy in development for MS, shows sustained benefits for the majority of patients after three years of treatment

... were presented at the 60th annual meeting of the American Academy of neurology (AAN) in Chicago, USA. "These new data demonstrate the exciting ... a convenient once-daily pill," said Professor Giancarlo Comi, Professor of neurology at the University Vita-Salute San Raffaele in Milan, Italy. "An effective ...

PTC Therapeutics Announces Additional Results from Phase 2 Study of PTC124 in Duchenne Muscular Dystrophy

... and study investigator, Carsten Bonnemann, M.D., Assistant Professor neurology and Pediatrics, Children's Hospital of Philadelphia and University of ... results, combined with the data presented earlier this month at the Child neurology Society meeting and North American Cystic Fibrosis Conference, further ...

Top-Line Efficacy Data Presented from Phase 2 Trial of Alemtuzumab in Multiple Sclerosis

... outcomes from this trial were presented by Alastair Compston, professor of neurology and the head of the Department of Clinical Neurosciences at the University ... to be presented at the 60th Annual Meeting of the American Academy of neurology next spring. "These results demonstrate the durability of the previously ...

PTC Therapeutics Announces Pharmacokinetic and Safety Results from Phase 2 Study of PTC124 in Duchenne Muscular Dystrophy

... - Data Presented at 36th Child neurology Society Annual Meeting - SOUTH PLAINFIELD, N.J., Oct. 11 /PRNewswire/ -- ... These data were presented today at the 36th Annual Meeting of the Child neurology Society (CNS) in Quebec City, Canada. (Logo: ...

Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression

... effective treatment for patients," said Dr. Ludwig Kappos, Professor of neurology and Clinical Neuroimmunology at the University of Basel, Switzerland and ... in multiple sclerosis: an expanded disability status scale (EDSS). neurology 1983; 33: 1444-52. (2) Rio J, Nos C, Tintore M, Tellez N, Galan I, Pelayo ...

Montefiore Medical Center and Albert Einstein College of Medicine Herald New Agreement To Continue Forty-Plus Year Historic Relationship

... leader in the research and treatment of diabetes, headaches , obesity, cough and sleep disorders , geriatrics and geriatric psychiatry , neurology and neurosurgery , adolescent and family medicine , HIV/AIDS and social and environmental medicine, among many other specialties. For ...

Neurointerventionists Expand Research to Quality of Life in Aneurysm Patients Following Minimally Invasive Coiling Treatment

... hemorrhage each year. About SNIS SNIS members are neurointerventional practitioners with backgrounds in neuroradiology, neurosurgery and neurology that come together in the shared discipline of neurointerventional surgery. Our practitioners specialize in minimally invasive and endovascular ...

Takeda Provides Update on the Investigational Fixed-Dose Combination of alogliptin and ACTOS(R) (pioglitazone HCl)

... innovative products to patients through a pipeline that includes compounds in development for diabetes, cardiovascular disease, gastroenterology, neurology and other conditions. Takeda is committed to striving toward better health for individuals and progress in medicine by developing superior ...

Mayo Clinic Study Finds Earliest Evidence of Memory Decline in Middle-Aged People at Genetic Risk for Alzheimer's Disease

... suspected, and well before the anticipated onset of clinically significant symptoms," said Richard J. Caselli , M.D., Chair of Mayo Clinic's neurology Department in Arizona and lead author of the research study. "While other age-sensitive cognitive skills also change, memory, specifically, appears ...

PTSD Associated With Higher Alzheimer's/Dementia Risk; Moderate Alcohol Consumption May Lower it

... investigated if PTSD increases the risk of developing dementia. To address this emerging issue, Kristine Yaffe, MD, Professor of Psychiatry, neurology and Epidemiology and Associate Chair of Research for the Department of Psychiatry at the University of California, San Francisco, and Chief of ...

Results From Trials of DHA in Alzheimer's Disease and Age-Related Cognitive Decline

... from the National Institute on Aging (NIA)-supported Alzheimer's Disease Cooperative Study (ADCS), led by Joseph Quinn, MD, Associate Professor of neurology at Oregon Health and Sciences University, conducted a double blind, randomized, placebo-controlled clinical trial comparing DHA and placebo in 402 ...

Takeda Receives FDA Complete Response Letter for Alogliptin, an Investigational Treatment for Type 2 Diabetes

... innovative products to patients through a pipeline that includes compounds in development for diabetes, cardiovascular disease, gastroenterology, neurology and other conditions. To learn more about these Takeda companies, visit www.tpna.com . ...

Jazz Pharmaceuticals and UCB Announce Second Phase III Study of Sodium Oxybate in Patients With Fibromyalgia Meets Primary Endpoints

... JAZZ ) is a specialty pharmaceutical company that identifies, develops and commercializes innovative treatments for important, underserved markets in neurology and psychiatry. For further information see www.JazzPharmaceuticals.com . About UCB UCB ( Brussels , Belgium , www.ucb.com ) is ...

Neurobiological Technologies' Partner, Celtic Pharma, Announces Results of XERECEPT(R) Phase 3 Clinical Program

... reduction in adverse side effects in the treatment of patients with brain tumors is an important goal," said Lawrence Recht, MD, Professor of neurology and Neurological Sciences, Stanford University Medical Center. "The results of these late-stage studies are encouraging, both in terms of lowering ...

Boston Scientific Welcomes Results of Brain Aneurysm Clinical Trial

... -- Boston Scientific Corporation (NYSE: BSX ) today welcomed publication of results from the ISAT clinical trial in The Lancet neurology showing patients with a ruptured intracranial aneurysm treated with endovascular coil embolization are 23 percent less likely to die within five ...

Lack of Food Variety Puts Kids With Autism at Risk for Poor Nutrition

... nutritional deficiencies. Researchers participating in studies were from the division of Developmental and Behavioral Pediatrics and division of neurology at Cincinnati Children's. Researchers from the department of Pathology at the University of Cincinnati participated in the study on food variety. ...

Two-Year Phase III Data Presented at AAN 61st Annual Meeting Show Positive Outcome of Cladribine Tablets in Patients With Multiple Sclerosis

... The data were presented today for the first time, as a late-breaking oral presentation at the 61st Annual Meeting of the American Academy of neurology (AAN) in Seattle, WA. "All primary and secondary endpoints of the CLARITY study were statistically significant and demonstrate that annual ...

New Studies on Once-Daily Extended Release Pramipexole Presented at American Academy of Neurology Annual Meeting

... in an extended release, once-daily formulation, for the treatment of Parkinson's disease (PD), are being presented today at the American Academy of neurology (AAN) 61st Annual Meeting in Seattle. The first study compared the efficacy, safety and tolerability of pramipexole extended release versus the ...

Merz Pharmaceuticals Announces Results of Three Clinical Trials With NT-201 (Botulinum Neurotoxin Type A Free From Complexing Proteins) in Movement Disorder Patients

... high biologic activity with low protein load, it is a neurotoxin that is free from complexing proteins," said David M. Simpson, M.D., Professor of neurology and Neuromuscular Diseases at Mount Sinai Medical Center in New York and a leading botulinum neurotoxin researcher. The NT-201 data will ...

Avineuro Pharmaceuticals, Inc. Announces Beginning of Phase I Clinical Studies of AVN-211, Potent Small Molecule for Treatment of Schizophrenia.

... March 11-15, 2009. About Avineuro Pharmaceuticals, Inc.: Avineuro discovers and develops novel small molecules for unmet medical needs in neurology and psychiatry. Avineuro emphasizes a rational approach to drug discovery that combines modern medicinal chemistry with streamlined pre-clinical and ...

Neuralstem's Human Stem Cells Integrate into Nervous System of Rats with Animal Model of ALS

... contacts with the motor neurons of rats with ALS-like symptoms, a paper published in the current online edition of the Journal of Comparative neurology reported. This constitutes evidence that the transplanted cells integrated into the nervous system of the host. The rats had a genetic mutation ...

Acanya(TM) Gel, a New Treatment for Moderate to Severe Acne, Launched by Coria Laboratories

... ) is a multinational specialty pharmaceutical company that develops and markets a broad range of pharmaceutical products primarily in the areas of neurology and dermatology. More information about Valeant can be found at www.valeant.com . FORWARD-LOOKING STATEMENTS: This press release ...

Gallbladder Removal Through Vagina Offers Minimally Invasive Alternative

... is recognized for providing exemplary patient care and state-of-the art advancements in the areas of cardiovascular care; women's health; oncology; neurology and neurosurgery; solid organ and soft tissue transplants and orthopaedics. Northwestern Memorial possesses nursing Magnet Status, the nation's ...

For Iraq Veterans, Headaches Continue After Traumatic Brain Injury

... For more information about the American Academy of Neurology, visit www.aan.com . The AAN 61st Annual Meeting, the world's largest gathering of neurology professionals, takes place April 25 to May 2, 2009, in Seattle. Visit www.aan.com/am for more information. To access 2009 AAN Annual ...

Young Smokers Increase Risk for Multiple Sclerosis

... more information about the American Academy of Neurology, visit www.aan.com . The AAN 61st Annual Meeting, the world's largest gathering of neurology professionals, takes place April 25 to May 2, 2009, in Seattle. Visit www.aan.com/am for more information. To access 2009 AAN Annual ...

Results of NeuroThera Effectiveness and Safety Trial - 2 (NEST-2) Presented at International Stroke Conference 2009

... stroke to 24 hours. We look forward to commencing NEST-3 to further investigate TLT," stated Professor Werner Hacke, M.D., Ph.D., Chairman of neurology at the University of Heidelberg, who will join Professor Zivin as Co-Chairman of the NEST-3 Steering Committee. About Acute Ischemic Stroke ...

Can Exercising Your Brain Prevent Memory Loss?

... For more information about the American Academy of Neurology, visit www.aan.com . The AAN 61st Annual Meeting, the world's largest gathering of neurology professionals, takes place April 25 to May 2, 2009, in Seattle. Visit www.aan.com/am for more information. To access 2009 AAN Annual ...

Foreign Medical Devices are in High Demand in Russia

... appliances - Other surgical and medical instruments - Cardiovascular devices - ENT devices - Nephrology and urology devices - neurology devices - Anesthesia and respiratory devices - Endoscopy devices - Drug delivery devices - In vitro diagnostics - Diabetes care ...

FDA Stem Cell Approval Breakthrough Laudable

... healing system has profound implications for every area of modern medicine. He holds a Masters degree in neurophysiology from the Department of neurology and Neurosurgery at Montreal's McGill University . http://www.christiandrapeau.com ...

Jazz Pharmaceuticals, Inc. Completes Enrollment in Second of Two Phase III Clinical Trials of Sodium Oxybate to Treat Fibromyalgia

... is a specialty pharmaceutical company that identifies, develops and commercializes innovative treatments for important, underserved markets in neurology and psychiatry. The Company has an unwavering commitment to improving care for patients with serious psychiatric and neurological conditions through ...

Cambridge Laboratories Announces Approval of Tetrabenazine in Spain

... disease patients with this important treatment. We are particularly pleased to have partnered in Spain with UCB, one of Europe's leading neurology players." A spokesperson from UCB said: "Our expertise within the CNS arena will allow us to maximize the value of this potential new therapy ...

Retigabine Significantly Reduces the Number of Seizures in Adults With Inadequately Controlled Partial-Onset Epilepsy

... specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology and dermatology. More information about Valeant can be found at http://www.valeant.com . Inquiries: GSK US Media inquiries: ...
Other Contents
(Date:12/19/2014)... Dec. 18, 2014  23andMe, Inc., the leading personal ... that pinpoints fine-scale differences in genetic ancestry of individuals ... Since immigrants first arrived more than four ... has served as a meeting place for peoples ... and the ongoing mixing of peoples with African, European, ...
(Date:12/17/2014)... , Dec. 16, 2014 Valencell, a ... its PerformTek biometric technology to industry leaders such as ... accurate, clinically validated, biometric wearable products. These products will ... in Las Vegas . ... is accurate, flexible and robust – with the clinical ...
(Date:12/11/2014)... --Research and Markets , ... ) has announced the addition of the ... their offering. One major trend ... multimodal biometric systems. Multimodal biometric systems utilize more ... and identification purposes. This helps to reduce the ...
Breaking Biology News(10 mins):23andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
(Date:12/24/2014)... Dr. Svetlana Gomer, MGS Tewksbury Dental, ... gathered with US Marines on November 14, 2014 for ... the Toys for Tots Literacy Program. This year’s ... books and audio books for the Toys for Tots ... Christmas. It represents another major strike in the battle ...
(Date:12/24/2014)... 2014 The report offers details on ... various market dynamics such as the key trends, the ... wait time for U.S. sports medicine, the impact of ... the challenges faced by the market. , Browse report ... The report also provides an overview of the global ...
(Date:12/24/2014)... Verde Pointe Dental Associates 2014 Ugly Holiday ... years homemade Christmas sweater lit up, but this years overall ... is Tandy Wilson for the second year in a row. ... Kimmerling DDS. "She took pictures of the entire staff and ... , "Every year I enjoy stopping by the dental ...
(Date:12/24/2014)... Dental implants benefit millions of individuals ... They offer the strongest and most secure hold for ... of tooth replacement. They will never slip out of ... for support, and they prevent the jaw from shrinking ... they are not suitable candidates for dental implants because ...
(Date:12/24/2014)... 24, 2014 Attorneys handling talcum powder ... update to their website, the Talcum Powder Ovarian ... talcum powder class action lawsuits and ovarian cancer claims. ... ovarian cancer updates at their website, which serves as ... ovarian cancer claims are not the same as class ...
Breaking Medicine News(10 mins):Health News:Dr. Svetlana Gomer, MGS Tewksbury Dental and Other Dentists Working With the U.S. Marines Strike Again In the Battle Against Illiteracy 2Health News:Dr. Svetlana Gomer, MGS Tewksbury Dental and Other Dentists Working With the U.S. Marines Strike Again In the Battle Against Illiteracy 3Health News:Sports Medicine Market Report 2014: Global Industry Analysis, Share, Size, Trends, Growth and Forecast report 2Health News:Verde Pointe Dental Associates Announces the 2014 Ugly Sweater Holiday Contest Winner 2Health News:Innovative Dental Implant Procedure to Gain Momentum in the New Year 2Health News:Talcum Powder Attorneys Explain Class Action Lawsuits 2Health News:Talcum Powder Attorneys Explain Class Action Lawsuits 3Health News:Talcum Powder Attorneys Explain Class Action Lawsuits 4
Other TagsOther Tags